Abstract Number: 1533 • 2018 ACR/ARHP Annual Meeting
Simulating Population Disability Outcomes for Alternative Treatment Pathways in Patients with Active Rheumatoid Arthritis
Background/Purpose: Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that causes joint pain and swelling, bone erosions, and deformity. This debilitating disease can severely…Abstract Number: 2504 • 2018 ACR/ARHP Annual Meeting
A More Time Under Remission Impacts in a Better Health-Related Quality of Life in Rheumatoid Arthritis Mestizo Population
Background/Purpose: In Rheumatoid Arthritis (RA), sustained remission is associated with less disability (1,2) , and this outcome should be the goal in the RA treatment;…Abstract Number: 519 • 2016 ACR/ARHP Annual Meeting
Greater Fatigue at Baseline and Female Gender Predict Worse Disability in Early RA Despite Treatment to Target: A Comparison of Two Observational Cohort Studies from the United Kingdom
Background/Purpose: Although disability is part of the ‘core set’ of outcomes for RA research recommended by OMERACT (1), current therapeutic strategies focus on inflammation. The…Abstract Number: 1545 • 2016 ACR/ARHP Annual Meeting
Vitamin D Insufficiency in Patients with Rheumatoid Arthritis and Healthy Controls and Correlation Between Vitamin D Levels and Disease Activity and Disability in RA Patients
Background/Purpose: Lower serum vitamin D levels have been shown to be associated with various autoimmune disorders including Rheumatoid Arthritis (RA). We undertook this study to…Abstract Number: 2675 • 2015 ACR/ARHP Annual Meeting
Has the Relationship Between Disease Activity and Disability in Rheumatoid Arthritis Changed?
Background/Purpose: Rheumatoid arthritis (RA) management paradigms have changed over the last two decades. Evidence now supports aggressive immunosuppression with early use of combination disease modifying…Abstract Number: 2679 • 2015 ACR/ARHP Annual Meeting
Development and Validation of a HAQ-Derived Tool to Detect Muscle Mass Deficits in Rheumatoid Arthritis
Background/Purpose: Rheumatoid Arthritis (RA) is associated with loss of muscle mass, exacerbating impairments in physical function. The 20-question Health Assessment Questionnaire (HAQ) is an accepted…Abstract Number: 1053 • 2014 ACR/ARHP Annual Meeting
Co-Morbidity Is Associated with Disease Severity in Early Rheumatoid Arthritis
Background/Purpose Co-morbidity has been shown to increase length of hospital stay and mortality in hospitalised patients. However, in early rheumatoid arthritis (eRA) co-morbidity may confound…Abstract Number: 2237 • 2013 ACR/ARHP Annual Meeting
Assessment Of Wage and Salary Growth In Patients With Rheumatoid Arthritis (RA)
Background/Purpose: RA negatively impacts patients' work outcomes. Treatment with tumor necrosis factor inhibitors (anti-TNFs) has been associated with improved work productivity and stability in RA.…Abstract Number: 2693 • 2012 ACR/ARHP Annual Meeting
Factors Associated with Person-Perceived Disability in Adults Aged 18+ with Rheumatoid Arthritis
Background/Purpose: Rheumatoid Arthritis (RA) is associated with high risk of disability (1). Loss of independence is negatively correlated with the person’s health and wellbeing (2).…Abstract Number: 2137 • 2012 ACR/ARHP Annual Meeting
Contribution of Disease Activity, Joint Damage and Comorbidity to Impairment (SOFI) and Disability (HAQ) in Rheumatoid Arthritis Patients Over 20 Years
Background/Purpose: To study the contribution of disease activity, joint damage and co-morbidity on development of impairment measured by signals of functional impairment (SOFI) and disability…Abstract Number: 826 • 2012 ACR/ARHP Annual Meeting
Predictors of Return to Work During 3 Years After Start of First Tumor Necrosis Factor Antagonist in a National Cohort of Biologics-Treated Patients with Rheumatoid Arthritis
Background/Purpose: To estimate predictors of return to work during 3 years following start of anti-TNF therapy in working-age RA patients with total work disability at…
ACR Meeting Abstracts